Serum tissue factor as a biomarker for renal clear cell carcinoma

Conclusions We have shown a 3-fold reduction in the median preoperative serum levels of TF in patients with clear cell RCC after surgery. We have also shown a difference of the same magnitude in the serum levels of TF compared with those of a control group of patients with benign diseases. TF appears to be a useful serum marker for the presence of clear cell RCC. Further studies are needed to validate these findings.
Source: International Braz J Urol - Category: Urology & Nephrology Source Type: research